MétaCan
Menu
Back to cohort
Record W1827906357 · doi:10.1161/atvb.35.suppl_1.692

Abstract 692: Therapeutic Inhibition of miR-33 Does Not Promote Obesity, Insulin Resistance or Hepatic Lipid Accumulation

2015· article· en· W1827906357 on OpenAlexaff
Denuja Karunakaran, Michèle Geoffrion, Danyk Barrett, Mary‐Ellen Harper, Christine Esau, Katey J. Rayner

Bibliographic record

VenueArteriosclerosis Thrombosis and Vascular Biology · 2015
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicMicroRNA in disease regulation
Canadian institutionsUniversity of Ottawa
Fundersnot available
KeywordsInsulin resistanceInternal medicineEndocrinologySteatosisLipid metabolismCholesterolCarbohydrate metabolismRespiratory exchange ratioGlucose homeostasisInsulinFatty liverObesityABCA1MedicineChemistryBiologyGeneBiochemistryDisease

Abstract

fetched live from OpenAlex

Inhibition of miR-33, a critical post-transcriptional regulator of cholesterol homeostasis, prevents atherosclerosis progression both dependently and independently of its effects on circulating HDL levels. However, recent studies suggest that genetic deletion or inhibition of miR-33 may adversely affect metrics of insulin resistance, lipid metabolism and hepatic steatosis. Given the therapeutic interest in miR-33 inhibitors for treating atherosclerosis, we sought to determine the effects of long-term pharmacological inhibition of miR33 in a mouse model of diet-induced obesity (DIO). Results: C57BL6/J mice were fed a high-fat diet in conjunction with anti-miR therapy (10mg/kg of control anti-miR or anti-miR33) for 20 weeks. There was significant but equivalent weight gain in all 3 groups. While anti-miR33 therapy increased total plasma cholesterol compared to control anti-miR treated mice (p≤0.01), there was no differences relative to PBS treated mice. Anti-miR33 treatment also resulted in a marked decrease in serum triglycerides relative to control anti-miR (29% decrease, p≤0.05) but once again not compared to PBS treated mice. Metrics of insulin resistance (GTT, ITT) were not altered in anti-miR33 treated mice relative to controls. Interestingly, indirect calorimetric measurements demonstrated that anti-miR33 treated mice had reduced respiratory exchange ratios (RER) compared to both control anti-miR and PBS treated mice (18% decrease, p≤0.05), suggesting an increase in fatty acid versus carbohydrate utilization in anti-miR33 treated mice. In addition, hepatic protein expression of known miR-33 target gene ABCA1 was de-repressed upon miR-33 inhibition, indicating that miR-33 was efficiently inhibited in this model. In contrast, putative miR-33 target gene SREBP-1 protein expression was not altered, nor were SREBP-1 downstream target genes FASN and ACC. Finally, anti-miR33 treated mice did not accumulate more lipids in their livers relative to control. In conclusion, we show in a DIO model that therapeutic silencing of miR-33 does not promote hepatic steatosis nor does it increase metrics of insulin resistance, suggesting that pharmacological inhibition of miR-33 may be a safe therapeutic for the treatment of atherosclerosis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.035

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0110.003

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.056
GPT teacher head0.305
Teacher spread0.249 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueArteriosclerosis Thrombosis and Vascular BiologySame topicMicroRNA in disease regulationFrench-language works237,207